ID: ALA5267893

Max Phase: Preclinical

Molecular Formula: C7H9F3N2O

Molecular Weight: 194.16

Associated Items:

Representations

Canonical SMILES:  OCCCc1c[nH]nc1C(F)(F)F

Standard InChI:  InChI=1S/C7H9F3N2O/c8-7(9,10)6-5(2-1-3-13)4-11-12-6/h4,13H,1-3H2,(H,11,12)

Standard InChI Key:  MAJMCQXRRMHIEJ-UHFFFAOYSA-N

Associated Targets(Human)

C-type lectin domain family 4 member M 115 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 194.16Molecular Weight (Monoisotopic): 194.0667AlogP: 1.35#Rotatable Bonds: 3
Polar Surface Area: 48.91Molecular Species: NEUTRALHBA: 2HBD: 2
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 0.56CX LogP: 1.51CX LogD: 1.51
Aromatic Rings: 1Heavy Atoms: 13QED Weighted: 0.76Np Likeness Score: -1.11

References

1. Sethi A, Sanam S, Alvala M..  (2021)  Non-carbohydrate strategies to inhibit lectin proteins with special emphasis on galectins.,  222  [PMID:34146913] [10.1016/j.ejmech.2021.113561]

Source